Global Cancer Registry Software Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Cancer registry is a computerized database which uses software solutions to organize, gather and store data of the cancer patients and evaluate cancer-specific upshots, situations and drug/medical device exposure. Growing number of cancer cases, increasing adoption of EHR, favorable government programs towards cancer and growing use of cancer patient registry data for post-marketing surveillance are the few factors responsible for high CAGR of the market over the forecast period.
The rising number of cancer cases globally support the market growth because it helps in automates data gathering for federal and state registries, which aids in tracking the efficacy of various treatment options. Additionally, the information gathered by the state registers assists in a better understanding and treatment of the disease. For instance, according to International Agency for Research on Cancer (IARC), approx. 19.3 million new cases of cancer are reported in UN regions in 2020. In the year 2040, it is anticipated that there would be about 28.4 million incident cases. Additionally, increasing number of accountable care organizations is anticipated to create the lucrative opportunity for the marker during forecast period. However, the privacy and data security-related concerns may stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Cancer Registry Software Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising prevalence of cancer, government funding initiatives to encourage the development of cancer registries and high investments in healthcare IT across the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of cancer, rising public private investment for healthcare infrastructure development would create lucrative growth prospects for the Cancer Registry Software market across Asia Pacific region.
Major market players included in this report are:
- Elekta
- Electronic Registry Systems, Inc.
- Onco, Inc.
- C/NET Solutions
- Rocky Mountain Cancer Data Systems
- McKesson Corporation
- IBM Corporation
- Ordinal Data Inc.
- Himagine Solutions Inc.
- CONDUENT Inc.
Recent Developments in the Market:
- In June 2020, Arbor Metrix Inc., situated in the United States, and the Society of Interventional Radiology (SIR) have collaborated. With the help of this collaboration, the IR Quality Registry will be made accessible, allowing analytics to be incorporated to enhance patient care.
Global Cancer Registry Software Market Report Scope:
- Historical Data: 2019-2020-2021
- Base Year for Estimation: 2021
- Forecast period: 2022-2029
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Type, Deployment Model, Database Type, Functionality, End-User, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
- Standalone Software
- Integrated Software
By Deployment Model:
By Database Type:
- Commercial Database
- Public Database
By Functionality:
- Cancer Reporting to Meet State and Federal Regulations
- Patient Care Management
- Medical Research & Clinical Studies
- Product Outcome Evaluation
By End-User:
- Government Organizations & Third-Party Administrators
- Hospitals & Medical Practices
- Private Players
- Pharmaceutical, Biotechnology, and Medical Device Companies
- Research Centers
By Region:
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Cancer Registry Software Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Cancer Registry Software Market, by Type, 2019-2029 (USD Billion)
- 1.2.3. Cancer Registry Software Market, by Deployment Model, 2019-2029 (USD Billion)
- 1.2.4. Cancer Registry Software Market, by Database Type, 2019-2029 (USD Billion)
- 1.2.5. Cancer Registry Software Market, by Functionality, 2019-2029 (USD Billion)
- 1.2.6. Cancer Registry Software Market, by End-User, 2019-2029 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Cancer Registry Software Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Cancer Registry Software Market Dynamics
- 3.1. Cancer Registry Software Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Growing number of cancer cases
- 3.1.1.2. Increasing adoption of HER
- 3.1.1.3. Favourable government programs towards cancer
- 3.1.2. Market Challenges
- 3.1.2.1. Privacy and data security-related concerns
- 3.1.3. Market Opportunities
- 3.1.3.1. Increasing number of accountable care organizations
Chapter 4. Global Cancer Registry Software Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cancer Registry Software Market, by Type
- 6.1. Market Snapshot
- 6.2. Global Cancer Registry Software Market by Type, Performance - Potential Analysis
- 6.3. Global Cancer Registry Software Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
- 6.4. Cancer Registry Software Market, Sub Segment Analysis
- 6.4.1. Standalone Software
- 6.4.2. Integrated Software
Chapter 7. Global Cancer Registry Software Market, by Deployment Model
- 7.1. Market Snapshot
- 7.2. Global Cancer Registry Software Market by Deployment Model, Performance - Potential Analysis
- 7.3. Global Cancer Registry Software Market Estimates & Forecasts by Deployment Model 2019-2029 (USD Billion)
- 7.4. Cancer Registry Software Market, Sub Segment Analysis
- 7.4.1. On-Premise
- 7.4.2. Cloud-Based
Chapter 8. Global Cancer Registry Software Market, by Database Type
- 8.1. Market Snapshot
- 8.2. Global Cancer Registry Software Market by Database Type, Performance - Potential Analysis
- 8.3. Global Cancer Registry Software Market Estimates & Forecasts by Database Type 2019-2029 (USD Billion)
- 8.4. Cancer Registry Software Market, Sub Segment Analysis
- 8.4.1. Commercial Database
- 8.4.2. Public Database
Chapter 9. Global Cancer Registry Software Market, by Functionality
- 9.1. Market Snapshot
- 9.2. Global Cancer Registry Software Market by Functionality, Performance - Potential Analysis
- 9.3. Global Cancer Registry Software Market Estimates & Forecasts by Functionality 2019-2029 (USD Billion)
- 9.4. Cancer Registry Software Market, Sub Segment Analysis
- 9.4.1. Cancer Reporting to Meet State and Federal Regulations
- 9.4.2. Patient Care Management
- 9.4.3. Medical Research & Clinical Studies
- 9.4.4. Product Outcome Evaluation
Chapter 10. Global Cancer Registry Software Market, by End-User
- 10.1. Market Snapshot
- 10.2. Global Cancer Registry Software Market by End-User, Performance - Potential Analysis
- 10.3. Global Cancer Registry Software Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
- 10.4. Cancer Registry Software Market, Sub Segment Analysis
- 10.4.1. Government Organizations & Third-Party Administrators
- 10.4.2. Hospitals & Medical Practices
- 10.4.3. Private Players
- 10.4.4. Pharmaceutical, Biotechnology, and Medical Device Companies
- 10.4.5. Research Centers
Chapter 11. Global Cancer Registry Software Market, Regional Analysis
- 11.1. Cancer Registry Software Market, Regional Market Snapshot
- 11.2. North America Cancer Registry Software Market
- 11.2.1. U.S. Cancer Registry Software Market
- 11.2.1.1. Type breakdown estimates & forecasts, 2019-2029
- 11.2.1.2. Deployment Model breakdown estimates & forecasts, 2019-2029
- 11.2.1.3. Database Type breakdown estimates & forecasts, 2019-2029
- 11.2.1.4. Functionality breakdown estimates & forecasts, 2019-2029
- 11.2.1.5. End-User breakdown estimates & forecasts, 2019-2029
- 11.2.2. Canada Cancer Registry Software Market
- 11.3. Europe Cancer Registry Software Market Snapshot
- 11.3.1. U.K. Cancer Registry Software Market
- 11.3.2. Germany Cancer Registry Software Market
- 11.3.3. France Cancer Registry Software Market
- 11.3.4. Spain Cancer Registry Software Market
- 11.3.5. Italy Cancer Registry Software Market
- 11.3.6. Rest of Europe Cancer Registry Software Market
- 11.4. Asia-Pacific Cancer Registry Software Market Snapshot
- 11.4.1. China Cancer Registry Software Market
- 11.4.2. India Cancer Registry Software Market
- 11.4.3. Japan Cancer Registry Software Market
- 11.4.4. Australia Cancer Registry Software Market
- 11.4.5. South Korea Cancer Registry Software Market
- 11.4.6. Rest of Asia Pacific Cancer Registry Software Market
- 11.5. Latin America Cancer Registry Software Market Snapshot
- 11.5.1. Brazil Cancer Registry Software Market
- 11.5.2. Mexico Cancer Registry Software Market
- 11.5.3. Rest of Latin America Cancer Registry Software Market
- 11.6. Rest of The World Cancer Registry Software Market
Chapter 12. Competitive Intelligence
- 12.1. Top Market Strategies
- 12.2. Company Profiles
- 12.2.1. Elekta
- 12.2.1.1. Key Information
- 12.2.1.2. Overview
- 12.2.1.3. Financial (Subject to Data Availability)
- 12.2.1.4. Product Summary
- 12.2.1.5. Recent Developments
- 12.2.2. Electronic Registry Systems, Inc.
- 12.2.3. Onco, Inc.
- 12.2.4. C/NET Solutions
- 12.2.5. Rocky Mountain Cancer Data Systems
- 12.2.6. McKesson Corporation
- 12.2.7. IBM Corporation
- 12.2.8. Ordinal Data Inc.
- 12.2.9. Himagine Solutions Inc.
- 12.2.10. CONDUENT Inc.
Chapter 13. Research Process
- 13.1. Research Process
- 13.1.1. Data Mining
- 13.1.2. Analysis
- 13.1.3. Market Estimation
- 13.1.4. Validation
- 13.1.5. Publishing
- 13.2. Research Attributes
- 13.3. Research Assumption